- Home
- ATLC vs NAGE Comparison
ATLC vs NAGE Comparison
Compare ATLC & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLC
- NAGE
- Stock Information
- Founded
- ATLC 1996
- NAGE 1999
- Country
- ATLC United States
- NAGE United States
- Employees
- ATLC N/A
- NAGE N/A
- Industry
- ATLC Finance: Consumer Services
- NAGE Medicinal Chemicals and Botanical Products
- Sector
- ATLC Finance
- NAGE Health Care
- Exchange
- ATLC Nasdaq
- NAGE Nasdaq
- Market Cap
- ATLC 900.3M
- NAGE 766.4M
- IPO Year
- ATLC 1999
- NAGE N/A
- Fundamental
- Price
- ATLC $58.15
- NAGE $7.41
- Analyst Decision
- ATLC Buy
- NAGE Strong Buy
- Analyst Count
- ATLC 7
- NAGE 3
- Target Price
- ATLC $78.71
- NAGE $17.00
- AVG Volume (30 Days)
- ATLC 75.3K
- NAGE 1.3M
- Earning Date
- ATLC 11-06-2025
- NAGE 11-04-2025
- Dividend Yield
- ATLC N/A
- NAGE N/A
- EPS Growth
- ATLC 35.13
- NAGE N/A
- EPS
- ATLC 5.69
- NAGE 0.22
- Revenue
- ATLC $457,158,000.00
- NAGE $116,303,000.00
- Revenue This Year
- ATLC $327.06
- NAGE $28.91
- Revenue Next Year
- ATLC $18.03
- NAGE $20.89
- P/E Ratio
- ATLC $9.78
- NAGE $34.43
- Revenue Growth
- ATLC 26.20
- NAGE 35.90
- 52 Week Low
- ATLC $35.36
- NAGE $3.39
- 52 Week High
- ATLC $78.91
- NAGE $14.69
- Technical
- Relative Strength Index (RSI)
- ATLC 48.07
- NAGE 37.17
- Support Level
- ATLC $53.31
- NAGE $7.20
- Resistance Level
- ATLC $59.59
- NAGE $7.59
- Average True Range (ATR)
- ATLC 2.87
- NAGE 0.38
- MACD
- ATLC 0.19
- NAGE 0.04
- Stochastic Oscillator
- ATLC 70.73
- NAGE 58.50
About ATLC Atlanticus Holdings Corporation
Atlanticus Holdings Corp invests in the financial services industry. It provides various credit and related financial services and products to or associated with the financially underserved consumer credit market. The operating business segments are the Credit as a Service (CaaS) and the Auto Finance segment. It generates maximum revenue from the Credit as a Service segment.
About NAGE Niagen Bioscience Inc. Common Stock
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.